Select your country/language
- United Kingdom
- Australia
- France – Français
- Italia
- Japan - 日本
- New Zealand
- Spain
- Sweden
- United States
Early detection and treatment can significantly reduce the risk of your patients. Click here to see the solutions we can offer at Medtronic.
This is a precancerous disease that, if left unmonitored or untreated, may progress to oesophageal cancer, otherwise know as Adenocarcinoma.
Oesophageal cancer is the 6th most common cause of cancer death in the UK1,2, together with gastric cancer, it accounts for 6% of all cancer deaths in men and 3% of all cancers death in women across Europe.
Frequent heartburn, or acid reflux, may be a sign of gastro-oesophageal reflux disease (GORD), approximately 10 to 15 percent of the European population experience weekly or more frequent incidents of reflux([FOOTNOTE=Dymedex Market Development Consulting, Strategic Market Assessment: Barxx-GI, October 30, 2014.],[ANCHOR=],[LINK=])
Up to 26,5 percent of people with chronic GORD may develop Barrett's oesophagus in their lifetime([FOOTNOTE=SEER Cancer Statistics Factsheets: Oesophageal Cancer. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/esoph.html Accessed March 2017.],[ANCHOR=],[LINK=])
People with dysplastic Barrett's oesophagus - meaning the abnormalities of the tissue or cells are significant - have a 25,6 percent risk of progressing to oesophageal adenocarcinoma (OAC) in their life([FOOTNOTE=Spechler et al., Barrett's Oesophagus. New England Journal of Medicine 2014. 371:836-45.],[ANCHOR=],[LINK=])
Only 15% of patients with Oesophageal Cancer survive for 5 years after diagnosis([FOOTNOTE=Barrett's Oesophagus & Oesophageal Cancer: The Statistics. Infographic, Medtronic 2016.],[ANCHOR=],[LINK=]). Cancer Research UK found that 59% of Oesophageal Cancer in UK is preventable([FOOTNOTE=Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.],[ANCHOR=],[LINK=])
Millions of people around the world suffer from acid reflux or chronic heartburn. Many don’t realize that it can develop into a more serious disease, Barrett’s oesophagus (BO)([FOOTNOTE=Vaezi M, Zehrai A, Yuksel E, Testing for refractory gastroesophageal reflux disease, ASGE Leading Edge, 2012 Vol 2, No 2, 1-13, American Society Gastroenterology Esdoscopy, Page 1.],[ANCHOR=],[LINK=])
Having Barrett’s oesophagus increases your risk of developing oesophageal adenocarcinoma (OAC), a form of oesophageal cancer, by 30–60 times([FOOTNOTE=Gilbert EW et al. Barrett’s esophagus: a review of the literature. J Gastrointest Surg 2011;15:708-1.],[ANCHOR=],[LINK=])
That’s why it’s so critical to get diagnosed. If detected early, Barrett’s oesophagus can be treated and reduce your risk for EAC([FOOTNOTE=Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-55.],[ANCHOR=],[LINK=])
We want to let patients and their families know that there are valuable tools available to physicians in diagnosing GORD and powerful treatment options for Barrett's oesophagus.
Watch the inspiring journey of Juan Carlos, a Barrett’s oesophagus patient.
With gastro-oesophageal reflux disease (GORD), stomach contents (food or liquid) leak backwards from the stomach into the oesophagus (the tube from the mouth to the stomach). This action can irritate the oesophagus, causing heartburn and other symptoms.
If you suffer from chronic heartburn, acid reflux, or similar symptoms, you may have a disease called gastroesophageal reflux disease (GORD).
Fill out this form and discuss the answers with a gastroenterologist, so together you can take the first step towards treatment.
Barrett’s oesophagus is a precancerous disease that affects the lining of the oesophagus. It occurs when stomach acids and enzymes re-enter the oesophagus over time and cause the cells to change, also known as intestinal metaplasia.
Barrett’s oesophagus is the primary risk factor for developing oesophageal cancer3. Complete the assessment to identify your risk level for Barrett’s oesophagus and oesophageal cancer.
Find a hospital that offers the full range of treatments and specializes in gastroesophageal reflux disease and Barrett’s oesophagus.
Medtronic provides this listing as a service. We have no vested interest in any specific hospitals, nor do we provide any recommendation, assurance, or guarantee with respect to their service.
Start a conversation with your GP to discuss further options.